Skip to content
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Genmab
  4. Genmab — Juni 2024

Genmab — Juni 2024

Planlagt Fastgjort Låst Flyttet Genmab
946 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • J Offline
    J Offline
    JKY_VH
    wrote on sidst redigeret af
    #183

    Ja, der er ikke noget der er så skidt at det ikke er godt for noget;-)

    1 Reply Last reply
    0
    • Helge_LarsenPI-redaktørH Offline
      Helge_LarsenPI-redaktørH Offline
      Helge_LarsenPI-redaktør
      wrote on sidst redigeret af
      #184

      Godmorgen 🙂

      1 Reply Last reply
      0
      • S Offline
        S Offline
        Stroka
        wrote on sidst redigeret af
        #185

        God morgen 🙂

        1 Reply Last reply
        0
        • B Offline
          B Offline
          bibob
          wrote on sidst redigeret af
          #186

          God morgen. 🙂

          1 Reply Last reply
          0
          • P Offline
            P Offline
            ProinvestorNEWS
            wrote on sidst redigeret af
            #187

            Dagens aktie er Halozyme Therapeutics, Inc..................

            Halozyme Therapeutics Inc er en biopharma platformsvirksomhed der forsker i, udvikler og kommercialiserer proprietære enzymer. Terapier fokuseret på humane enzymer
            Fokuserer på at udvikle sine proprietære produkter inden for terapeutiske områder med udækkede medicinske behov, med fokus på onkologi, og licensere sin teknologi til biofarmaceutiske virksomheder til i fællesskab at udvikle produkter. https://proinvestor.com/boards/120777

            1 Reply Last reply
            0
            • H Offline
              H Offline
              Hen
              wrote on sidst redigeret af
              #188

              Om Mim8: https://www.euroinvestor.dk/nyheder/en-af-novo-nordisks-mulige-fremtidige-guldaeg-skal-gaa-i-sporene-af-en?utm_medium=Social&utm_source=Facebook&fbclid=IwZXh0bgNhZW0CMTEAAR0ckWGSP4lNThfhuheAu2qU232PDDntF2bSQIbzFIqGKg62dXa7eqYsdwc_aem_AWjIGIrvZvgKBRDykTP7tgPJqwy47lT6EySK1GhWGJnsegRrD-JAarOcD8nQ9d3372EjpMJWpcgoCQNwupFjmoqu#Echobox=1717517388

              1 Reply Last reply
              0
              • Helge_LarsenPI-redaktørH Offline
                Helge_LarsenPI-redaktørH Offline
                Helge_LarsenPI-redaktør
                wrote on sidst redigeret af
                #189

                Genmab to Participate in a Fireside Chat at the Goldman Sachs 45th Annual Global Healthcare Conference https://proinvestor.com/investornyt/1169144/genmab-to-participate-in-a-fireside-chat-at-the-goldman-sachs-45th-annual-global-healthcare-conference

                1 Reply Last reply
                0
                • T Offline
                  T Offline
                  transalp
                  wrote on sidst redigeret af
                  #190

                  Go morgen.. 🙂

                  1 Reply Last reply
                  0
                  • E Offline
                    E Offline
                    E_L
                    wrote on sidst redigeret af
                    #191

                    Halozyme Announces Issuance of New European Patent for ENHANZE® Drug Delivery Platform https://markets.ft.com/data/announce/full?dockey=600-202406051605PR_NEWS_USPRX____LA32624-1

                    1 Reply Last reply
                    0
                    • D Offline
                      D Offline
                      dagensaktie.dk
                      wrote on sidst redigeret af
                      #192

                      Tak for info omkring det nye europæiske patent.

                      1 Reply Last reply
                      0
                      • SolsenS Offline
                        SolsenS Offline
                        Solsen
                        wrote on sidst redigeret af
                        #193

                        Så får Genmab lov til at betale deres andel frem til marts 2029 for salg i Europa. Men vi vel forvente at US andelen bliver billigere fra i år.

                        1 Reply Last reply
                        0
                        • SolsenS Offline
                          SolsenS Offline
                          Solsen
                          wrote on sidst redigeret af
                          #194

                          Undkyld US patentet udløber i 2027

                          1 Reply Last reply
                          0
                          • P Offline
                            P Offline
                            peter12
                            wrote on sidst redigeret af
                            #195

                            Det undrer mig at de bare kan forlænge ?

                            1 Reply Last reply
                            0
                            • SolsenS Offline
                              SolsenS Offline
                              Solsen
                              wrote on sidst redigeret af
                              #196

                              0,25 % ned fra ecb

                              1 Reply Last reply
                              0
                              • SolsenS Offline
                                SolsenS Offline
                                Solsen
                                wrote on sidst redigeret af
                                #197

                                Lad det være begyndelse på en rentenedtur, som vi aktionærer vil kunne få glæde af.

                                1 Reply Last reply
                                0
                                • J Offline
                                  J Offline
                                  JKY_VH
                                  wrote on sidst redigeret af
                                  #198

                                  enig Solsen

                                  1 Reply Last reply
                                  0
                                  • SolsenS Offline
                                    SolsenS Offline
                                    Solsen
                                    wrote on sidst redigeret af
                                    #199

                                    HALO hæver guidance med $80 mln for 2024. Kan ikke lige gennemskue tallene. Men muligt at JNJ og Genmab skal dele den udgift. https://finance.yahoo.com/news/halozyme-raises-full-2024-financial-123000685.html

                                    1 Reply Last reply
                                    0
                                    • E Offline
                                      E Offline
                                      E_L
                                      wrote on sidst redigeret af
                                      #200

                                      i can't say that i understand what happens here to be honest, how they can have adjusted the patent on an existing product..

                                      1 Reply Last reply
                                      0
                                      • SolsenS Offline
                                        SolsenS Offline
                                        Solsen
                                        wrote on sidst redigeret af
                                        #201

                                        Yes quite strange.

                                        1 Reply Last reply
                                        0
                                        • SolsenS Offline
                                          SolsenS Offline
                                          Solsen
                                          wrote on sidst redigeret af
                                          #202

                                          Link Preview Image
                                          Celebrating 25 Years of Genmab! Today, we celebrated Genmab's 25th anniversary at their headquarters in Valby. Genmab’s CEO, Jan van de Winkel, opened the market together with employees, marking a… | Peter Legind-Hansen

                                          Celebrating 25 Years of Genmab! Today, we celebrated Genmab's 25th anniversary at their headquarters in Valby. Genmab’s CEO, Jan van de Winkel, opened the market together with employees, marking a memorable moment for the company. We are proud to have Genmab among the strong listed companies on Nasdaq Copenhagen, contributing to Denmark's growth, innovation, and job creation. Nasdaq Copenhagen will continue to follow Genmab's success and innovation in the years to come🚀 Jan van de Winkel, Ph.D., Birgitte Stephensen, Marisol Mendez Peron, Solrun Sigfusdottir Øfjord, Carsten Borring, Sara Nolkrantz

                                          favicon

                                          LinkedIn (www.linkedin.com)

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper